We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NBN:NASDAQNortheast Bank Analysis

Data as of 2026-09-01 - not real-time

$124.80

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Northeast Bank trades at $124.80, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. The last 30 days have lost 5.3%. RSI sits at 39.1, which reads as approaching oversold, and MACD momentum is bearish. Recent trading has carved out support near $124.67 and resistance around $137.64.
On valuation the read is undervalued — earnings multiple of 9.8 versus a 16.8 sector average, below the peer group. The average analyst target implies 15.0% above today's level. Revenue is growing at 11.3% on a 45.4% profit margin. The 0.03% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 36.0%, a beta of 0.90 and a maximum drawdown of 27.6%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.

Top Market Events

Northeast Bank recently reported its fourth-quarter 2026 results, with net interest income of US$60.Northeast Bank NBN reports a 29% increase in annual net income, strong returns, and significant loan volume despite...PORTLAND, Maine, July 27, 2026 GLOBE NEWSWIRE -- Northeast Bank the 'Bank” NASDAQ: NBN , a Maine-based bank, today...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 117.31
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 9.8 versus sector average of 16.8
  • Trading above the 200-day average of 117.31

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 9.8 versus sector average of 16.8
  • Analyst targets imply +15.0% versus the current price
  • Profit margin of 45.4% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth11.30%
Profit Margin45.36%
P/E Ratio9.8
ROE19.57%
ROA2.26%
P/B Ratio1.9
Op. Cash Flow$-62539000
Industry P/E16.8

Technical Analysis

TrendBullish
RSI39.1
Support$124.67
Resistance$137.64
MA 20$131.46
MA 50$131.01
MA 200$117.31
MACDBearish
VolumeStable
Fear & Greed Index92.86

Valuation

Target Price$143.50
Upside/Downside14.98%
GradeUndervalued
TypeBlend
Dividend Yield0.03%

Risk Assessment

Beta0.90
Volatility36.04%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.